Thermo Fisher Scientific Inc – Consensus Indicates Potential 26.8% Upside
Thermo Fisher Scientific Inc with ticker code (TMO) now have 22 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 715 and 525 with a mean TP of 659.91. Now with the previous closing price of 520.29 this would indicate that there is a potential upside of 26.8%. There is a 50 day moving average of 567.14 while the 200 day moving average is 570.34. The market capitalisation for the company is $204,040m. Company Website: https:||www.thermofisher.com [stock_market_widget type="chart" template="basic" color="green" assets="TMO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $258,794m based on the market concensus. Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company''s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Thermo Fisher Scientific Inc – Consensus Indicates Potential 26.8% Upside
Thermo Fisher Scientific Inc with ticker code (TMO) now have 22 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 715 and 525 with a mean TP of 659.91. Now with the previous closing price of 520.29 this would indicate that there is a potential upside of 26.8%. There is a 50 day moving average of 567.14 while the 200 day moving average is 570.34. The market capitalisation for the company is $204,040m. Company Website: https:||www.thermofisher.com [stock_market_widget type="chart" template="basic" color="green" assets="TMO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $258,794m based on the market concensus. Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company''s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.